Frick MH - Search Results

1

Relationship of skeletal muscle fiber type to serum high density lipoprotein cholesterol and apolipoprotein A-I levels.

Tikkanen HO, Härkönen M, Näveri H, Hämäläinen E, Elovainio R, Sarna S, Frick MH. Tikkanen HO, et al. Among authors: frick mh. Atherosclerosis. 1991 Sep;90(1):49-57. doi: 10.1016/0021-9150(91)90243-v. Atherosclerosis. 1991. PMID: 1799397

2

The Helsinki Heart Study: basic design and randomization procedure.

Mänttäri M, Elo O, Frick MH, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, et al. Mänttäri M, et al. Among authors: frick mh. Eur Heart J. 1987 Oct;8 Suppl I:1-29. doi: 10.1093/eurheartj/8.suppl_i.1. Eur Heart J. 1987. PMID: 3322826 Clinical Trial.

3

High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.

Alber HF, Wanitschek MM, de Waha S, Ladurner A, Suessenbacher A, Dörler J, Dichtl W, Frick M, Ulmer H, Pachinger O, Weidinger F. Alber HF, et al. Eur J Clin Invest. 2008 Jun;38(6):372-80. doi: 10.1111/j.1365-2362.2008.01954.x. Eur J Clin Invest. 2008. PMID: 18489399

4

R643G polymorphism in PECAM-1 influences transendothelial migration of monocytes and is associated with progression of CHD and CHD events.

Elrayess MA, Webb KE, Bellingan GJ, Whittall RA, Kabir J, Hawe E, Syvänne M, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Miller GJ, Humphries SE. Elrayess MA, et al. Among authors: frick mh. Atherosclerosis. 2004 Nov;177(1):127-35. doi: 10.1016/j.atherosclerosis.2004.06.009. Atherosclerosis. 2004. PMID: 15488875

5

Serum homocysteine concentrations, gemfibrozil treatment, and progression of coronary atherosclerosis.

Syvänne M, Whittall RA, Turpeinen U, Nieminen MS, Frick MH, Kesäniemi YA, Pasternack A, Humphries SE, Taskinen MR. Syvänne M, et al. Among authors: frick mh. Atherosclerosis. 2004 Feb;172(2):267-72. doi: 10.1016/j.atherosclerosis.2003.10.003. Atherosclerosis. 2004. PMID: 15019536 Clinical Trial.

6

Remnant-like lipoprotein particle cholesterol concentration and progression of coronary and vein-graft atherosclerosis in response to gemfibrozil treatment.

Karpe F, Taskinen MR, Nieminen MS, Frick MH, Kesäniemi YA, Pasternack A, Hamsten A, Syvänne M. Karpe F, et al. Among authors: frick mh. Atherosclerosis. 2001 Jul;157(1):181-7. doi: 10.1016/s0021-9150(00)00700-0. Atherosclerosis. 2001. PMID: 11427219 Clinical Trial.

7

The 5A/6A polymorphism in the promoter of the stromelysin-1 (MMP-3) gene predicts progression of angiographically determined coronary artery disease in men in the LOCAT gemfibrozil study. Lopid Coronary Angiography Trial.

Humphries SE, Luong LA, Talmud PJ, Frick MH, Kesäniemi YA, Pasternack A, Taskinen MR, Syvänne M. Humphries SE, et al. Among authors: frick mh. Atherosclerosis. 1998 Jul;139(1):49-56. doi: 10.1016/s0021-9150(98)00053-7. Atherosclerosis. 1998. PMID: 9699891 Clinical Trial.

8

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol.

Syvänne M, Nieminen MS, Frick MH, Kauma H, Majahalme S, Virtanen V, Kesäniemi YA, Pasternack A, Ehnholm C, Taskinen MR. Syvänne M, et al. Among authors: frick mh. Circulation. 1998 Nov 10;98(19):1993-9. doi: 10.1161/01.cir.98.19.1993. Circulation. 1998. PMID: 9808595 Clinical Trial.

9

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. Frick MH, et al. N Engl J Med. 1987 Nov 12;317(20):1237-45. doi: 10.1056/NEJM198711123172001. N Engl J Med. 1987. PMID: 3313041 Clinical Trial.

10

Efficacy of gemfibrozil in dyslipidaemic subjects with suspected heart disease. An ancillary study in the Helsinki Heart Study frame population.

Frick MH, Heinonen OP, Huttunen JK, Koskinen P, Mänttäri M, Manninen V. Frick MH, et al. Ann Med. 1993 Feb;25(1):41-5. doi: 10.3109/07853899309147855. Ann Med. 1993. PMID: 8435186 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results